---
category: news
title: "As PD-(L)1 dis­rup­tors suf­fer set­backs, Check­point touts an­oth­er win"
excerpt: "FDA officials put a dent in some biopharmas’ quest to disrupt PD-(L)1 pricing, as many had attempted to shuttle through drugs using data from single-country trials. But Checkpoint Therapeutics is continuing to build out a case for its own checkpoint inhibitor,"
publishedDateTime: 2022-06-16T14:35:00Z
originalUrl: "https://endpts.com/as-pd-l1-disruptors-suffer-setbacks-checkpoint-touts-another-win/"
webUrl: "https://endpts.com/as-pd-l1-disruptors-suffer-setbacks-checkpoint-touts-another-win/"
type: article

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - AI in Robotics
  - AI

secured: "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;9henTDcLVMkl+MkgrB4H8w=="
---

